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ABSTRACT
OBJECTIVES This study sought to test the feasibility of a purpose-built, integrated software platform to process,
analyze, and overlay cardiac magnetic resonance (CMR) data in real time within a cardiac catheter laboratory and mag-
netic resonance imaging scanner in the same facility with the ability to transfer patients from one to the other (X-MRI)
environment to guide left ventricular (LV) lead implantation.
BACKGROUND Suboptimal LV lead position is a major determinant of poor cardiac resynchronization therapy (CRT)
response, and the optimal site is highly patient speciﬁc. Pacing myocardial scar is associated with poorer outcomes;
conversely, targeting latest mechanical activation (LMA) may improve them.
METHODS Fourteen patients (age 74  5.1 years; New York Heart Association functional class: 2.7  0.4; 86% ischemic
with ejection fraction 27  7.6%; QRSd: 157  19 ms) underwent CMR followed by immediate CRT implantation using
derived scar and dyssynchrony data, overlaid onto ﬂuoroscopy in an X-MRI suite. Rapid LV segmentation enabled detailed
scar quantiﬁcation, identiﬁcation of LMA segments, and selection of myocardial targets. At coronary venography, the
CMR-derived 3-dimensional shell was fused, enabling identiﬁcation of viable venous targets subtended by target
segments for LV lead placement.
RESULTS The platform was successful in all 14 patients, of whom 10 (71%) were paced in pre-procedurally deﬁned
target segments. Pacing in CMR-deﬁned target segments (out of scar) showed a signiﬁcant decrease in the LV capture
threshold (mean difference: 2.4 [1.5 to 3.2]; p < 0.001) and shorter paced QRS duration (mean difference: 25 [15 to 34];
p < 0.001) compared with pacing in areas of CMR determined scar. In 5 (36%) patients with extensive scar in the
posterolateral wall, CMR guidance enabled successful lead delivery in an alternative anatomically favorable site.
Radiation dose and implant times were similar to historical controls (p ¼ NS).
CONCLUSIONS Real-time CMR-guided LV lead placement is feasible and achievable in a single clinical setting and may
prove helpful to preferentially select sites for LV lead placement. (J Am Coll Cardiol EP 2017;-:-–-) © 2017 The
Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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C ardiac resynchronization therapy(CRT) is a highly efﬁcacious treat-ment for symptomatic patients
with heart failure, severe left ventricular
(LV) dysfunction, and broad QRS duration
(1,2). Despite 2 decades of delivering biven-
tricular pacing for selected patients with
heart failure, 30% to 50% fail to undergo LV
remodeling (3), with most implanters using
empirical placement of the LV lead on the
posterolateral wall. However, the optimal
site for LV stimulation is highly patient spe-
ciﬁc (4) and suboptimal lead position is a ma-
jor determinant of poor response (5). LV lead
positioning in or near areas of myocardial
ﬁbrosis is associated with poorer outcomes
(6–8). Furthermore, targeting LV myocardial
segments with latest mechanical activation
using speckle tracking echocardiography has
demonstrated utility in improving CRT out-
comes in single-center randomized studies
(9,10). Echocardiography, however, is a high-
ly user-dependent imaging modality and the
reproducibility of dyssynchrony metrics is
limited (11,12). Cardiac magnetic resonance
(CMR) imaging has recently emerged as a highly valu-
able modality providing unparalleled image quality
and information on etiology for patients with heart
failure (6); furthermore, it can delineate the location
and burden of myocardial scar through late gadolin-
ium enhancement sequences (13) and provide valu-
able data on mechanical dyssynchrony (14) and LV
contraction patterns (15), both of which can inform
appropriate placement of the LV lead. We have previ-
ously demonstrated the ability to overlay CMR-
derived anatomy, scar, and dyssynchrony data onto
ﬂuoroscopy for guiding the placement of the LV
lead (16,17). This resulted in improved acute response
and chronic echocardiographic response above the
rates in a standard nonguided approach. However,
the large quantity of data, associated lengthy compu-
tational processing time, and highly manual process,
as well as software limitations at that time meant
CMR scans were performed at least 2 weeks before
the implant.
The ability to process and display such informa-
tion in real time would represent a signiﬁcant
advance in the ability to use CMR guidance. In this
paper, we report the ﬁrst demonstration of a
real-time, purpose-built user interface in a hybrid
cardiac catheter laboratory and magnetic resonance
imaging scanner in the same facility with the ability
to transfer patients from one to the other (X-MRI)
facility to enable the processing, analysis and fusion
of CMR-derived data to guide the implanting physi-
cian in optimizing the deployment of an LV lead for
CRT delivery. Using this technique, the implanting
physician can use contemporaneous gold standard
myocardial imaging to avoid regions of scar while
targeting late activating segments, thereby permit-
ting imaging-guided LV lead implantation in a single
procedure.
METHODS
This study complied with the Declaration of Helsinki
and the protocol was approved by the local ethics
committee. Informed written consent was obtained
from each patient. A comprehensive CRT pre-
assessment included New York Heart Association
class, Minnesota Living with Heart Failure Question-
naire score, 6-min walk distance, peak oxygen uptake
on cardiopulmonary exercise testing, and echocar-
diographic assessment of LV systolic function with
2-dimensional and 3-dimensional (3D) datasets. Pa-
tients with a contraindication to CMR or signiﬁcant
renal impairment (estimated glomerular ﬁltration
rate: <30 ml/min/1.73 m2) were excluded. Patients
fulﬁlling standard CRT criteria (New York Heart
Association functional class II-IV drug refractory
heart failure, LV ejection fraction <35%, and QRS
>120 ms) were included in the study.
INTEGRATED SOFTWARE MODULE. A custom-made
software platform developed by the Department of
Imaging Sciences & Biomedical Engineering and
Siemens Healthineers was integrated in the X-MRI
facility incorporating a Magnetom Aera 1.5T MRI
scanner and adjacent Artis Q biplane Angiography
system (Siemens Magnetom Artis Combi Suite,
Siemens Healthcare GmbH, Erlangen, Germany).
The platform was installed on a dedicated proto-
type workstation connected to the biplane x-ray sys-
tem. It was designed for fast, automated data
processing to enable information to be extracted from
MRI and visualized in the time it takes to transfer the
patient from the MRI to angiography suite to mini-
mize any disruption. The platform includes automatic
intra- and inter-MRI protocol slice registration,
automatic LV segmentation, semiautomatic scar seg-
mentation and metrics for mechanical dyssynchrony,
scar distribution, burden, and transmurality. After
each automated task, the clinician is given the op-
portunity to verify and manually adjust the results.
PATIENT FLOW AND CRT IMPLANT. Respiratory and
cardiac-gated CMR images were acquired. Two-, 3-,
and 4-chamber and multiple slice short-axis balanced
steady-state free-precession images were acquired
ABBR EV I A T I ON S
AND ACRONYMS
CMR = cardiac magnetic
resonance
CRT = cardiac
resynchronization therapy
CS = coronary sinus
CT = computed tomography
3D = 3-dimensional
FA = ﬂip angle
LGE = late gadolinium
enhancement
LV = left ventricular
QLV = ﬁrst ventricular
depolarization (earliest onset
QRS duration on surface 12-
lead electrocardiogram) to the
nadir signal on the LV lead
electrogram
TE = echo time
TR = repetition time
X-MRI = cardiac catheter
laboratory and MRI scanner in
the same facility with the
ability to transfer patients from
one to the other
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during breath hold (repetition time [TR]: 2.4 ms; echo
time [TE]: 1.2 ms; ﬂip angle [FA]: 52; acquired spatial
resolution: 1.3 to 1.8  1.9 to 2.8 mm; bandwidth: 930
Hz/pixel; 6-mm slice thickness [long], 8-mm slice
thickness [short]) using an 18-channel body coil and a
24-channel spine coil. Late gadolinium enhancement
(LGE) sequences in the same views (TR: 2.4 ms;
TE: 1.2 ms; FA: 45; acquired spatial resolution: 1.10 
2.5 mm; bandwidth: 780 Hz/pixel; 8-mm slice thick-
ness with 2-mm gaps) was performed 10 to 15 min
following administration of 0.2 mmol/kg Gadovist
(Bayer Healthcare, Berlin, Germany) using conven-
tional inversion recovery techniques to identify areas
of myocardial ﬁbrosis (13). Following completion of
the scan, the patient was transferred directly to the
catheter laboratory (Combi Dockable Table, Siemens
Healthcare GmbH) and prepared for CRT implanta-
tion, which began immediately after the scan.
Simultaneously, the CMR data were uploaded, pro-
cessed, and analyzed on the prototype platform using
the following steps (Figure 1):
1. LV epicardial and endocardial automated seg-
mentation with manual adjustment where
necessary.
2. Registration of cine and LGE sequences.
3. Delineation of myocardial ﬁbrosis.
4. Review of location, burden, and transmurality of
myocardial ﬁbrosis on a 16-segment American
Heart Association (AHA) bull’s-eye plot and the
associated regional dyssynchrony curves to select
optimal target myocardial segments for LV
delivery.
LV SEGMENTATION AND MECHANICAL DYSSYN-
CHRONY COMPUTATION. The automated segmenta-
tion algorithm uses a combination of landmark
detection and discrimination between the myocar-
dium and blood pool in each short- and long-axis slice
to create a 3D mesh model. The algorithms on which
this is based have been previously described (18).
Epicardial and endocardial segmented contours are
divided into basal, mid, and apical segments. Identi-
ﬁcation of the right ventricular insertion points
further divides segments in line with AHA-
recommended nomenclature. Segmental endocardial
volumes are computed by multiplication of segmental
area by slice thickness. Each AHA regional volume is
calculated throughout the cardiac cycle (25 to 30
phases) to produce volume vs. time curves. Time to
minimum endocardial volume is assumed to be the
time to peak strain and expressed as a fraction of the
cardiac cycle length, denoted by a colored dot on
each segmental curve (lower left panel, Figure 2).
The mechanical activation curves are generated
automatically after the user conﬁrms the segmenta-
tion of epicardial and endocardial shells from the
short-axis cine sequences and has reviewed these
segmentations tracking over the cardiac cycle length.
MYOCARDIAL FIBROSIS IDENTIFICATION. The cine
short-axis sequences are ﬁrst registered to the LGE
sequences to translate myocardial ﬁbrosis to the LV
mesh. Subsequently, an automated algorithm com-
putes and highlights regions of scar (LGE) after the
user identiﬁes a region of healthy tissue; LGE was
deﬁned as 2 standard deviations from the mean gray
level. Users can adjust and manually add or remove
areas of ﬁbrosis while reviewing each slice.
DATA REVIEW AND TARGET SELECTION. Following
the steps described previously, a guidance display is
shown from which physicians select target segments
according to the principle of avoiding myocardial scar
and targeting areas of mechanical dyssynchrony
(latest time to peak contraction) in line with
our previously published work (15) (Figure 2).
FIGURE 1 Patient and Data Processing Workﬂow
CMR ¼ cardiac magnetic resonance; CS ¼ coronary sinus; MRI ¼ magnetic resonance
imaging; XMR ¼ cardiac catheter laboratory and MR scanner in the same facility with the
ability to transfer patients from one to the other; XR ¼ x-ray.
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Where there was extensive myocardial ﬁbrosis, seg-
ments with the smallest scar burden and trans-
murality were selected. Septal segments were
excluded because epicardial LV stimulation in this
region does not achieve effective resynchronization.
Where scar was absent, target segments with the most
delayed time to minimum volume were chosen. Seg-
ments with a minimal change in volume and there-
fore reduced endocardial strain were excluded for
selection on the basis of likely nonviability and pre-
viously published work linking LV placement in such
regions with poor CRT outcomes (19).
IMAGE GUIDANCE. A 3D model derived from CMR
was coregistered with x-ray images using multi-
modality imaging markers placed on the left side of
the chest overlying the heart (Beekley Medical,
Bristol, Connecticut) and visible on both CMR and
x-ray images. A 3D spoiled gradient echo, time-
resolved angiography with interleaved stochastic
trajectories sequence was used to identify the
adhesive markers (TR: 2.56; TE: 0.9; FA: 30; slice
thickness: 1.3 mm; acquired spatial resolution:
1.3  1.9 mm) on CMR and these were registered to
biplane ﬂuoroscopic images using the platform. Six
FIGURE 2 Prototype Display
This display screen is seen following the processing of the CMR dataset and is mimicked on the large screen in the catheter laboratory. Total
scar burden calculated as a mean of all myocardial segments. (Top middle) Scar distribution denoted in gray upon an American Heart Asso-
ciation 16-segment model. (Top right) Scar burden (% scar per myocardial segment volume), displayed in 5% ranges. (Bottom right) Scar
transmurality demonstrating the mean transmurality from endocardium to epicardium. Those segments >50% transmural myocardial ﬁbrosis
are also denoted in red. (Bottom left) Mechanical activation curves for the 16 segments, corresponding to the colors shown in the middle
panels. Endocardial tracking of the left ventricle provides absolute changes in the volume per segment (ml, y axis) over the cardiac cycle
(0% end diastole, 30% to 50% end systole, 100% end diastole). Because these are absolute volume changes, the apical segments are always
at the bottom because they have a smaller start and end volume. When the user hovers over a segment in the top middle panel, the associated
volume time curve appears in bold; in this case, the target posterolateral segment is shown. (Bottom middle) Target selection panel. Upon
reviewing the scar location, burden, transmurality, and mechanical activation curves, target segments are chosen (seen here in white; basal
anterior, mid-posterolateral). EDV ¼ end-diastolic volume; EF ¼ ejection fraction; ESV ¼ end-systolic volume; SDI ¼ systolic dyssynchrony
using endocardial tracking of CMR cine images in short and long axis; other abbreviations as in Figure 1.
Behar et al. J A C C : C L I N I C A L E L E C T R O P H Y S I O L O G Y V O L . - , N O . - , 2 0 1 7
Real-Time CMR-Guided CRT Implantation - 2 0 1 7 :- –-
4
degrees of freedom, translation, and rotation ensured
the accuracy of the registration in orthogonal planes.
Following this process, the CMR-derived 3D model is
registered to the x-ray coordinate system; subsequent
x-ray acquisitions during the case are displayed with
instantaneous overlay of the correctly oriented 3D
model (Figure 3).
Steps 1 through 4 were completed while the patient
was being prepared for the implantation. Following
coronary sinus (CS) cannulation, occlusive venog-
raphy in right anterior oblique, anteroposterior, and
left anterior oblique projections were obtained and
instantaneously fused with the CMR-derived 3D
model of the patient’s left ventricle (both epicardium
and endocardium), as shown in Figure 4. The number
and anatomical location of viable epicardial coronary
venous targets was immediately visualized on the
AHA 16-segment plot. Scar location and target selec-
tion meshes could be selectively highlighted to guide
LV lead positioning (Figure 4). LV lead deployment
was performed in the standard fashion aiming to
place the lead in the targeted segment when CS
anatomy was favorable and the target threshold
was <2.5 V at 0.5 ms with no phrenic nerve stimula-
tion at 10 V. A quadripolar LV lead was used in all
cases.
Before ﬁnalizing the LV lead position, to further
validate the guidance system in relation to scar and
local electrical activation (QLV), all epicardial veins
(able to receive an LV lead) were tested. Multiple
vector conﬁgurations were attempted along each vein
where possible and the QLV (ms), capture thresholds
(V), and paced QRS (ms) were measured.
STATISTICS. A test for normality (Shapiro-Wilk) was
performed for each variable. Continuous variables
with a Gaussian distribution were described using
mean  standard deviation; those with non-normal
distribution were described with median, inter-
quartile range. Categorical data were described by an
absolute number of occurrences and associated fre-
quency (%). Because of different numbers of multiple
measurements per patient, an ordinary Student t test
would not be appropriate and a mixed-effect model
was performed. Results were considered statistically
signiﬁcant at p < 0.05. Analysis was performed on
PASW Statistics 22 (SPSS Inc., Chicago, Illinois) and
Stata (StataCorp, 2014, Statistical Software, College
Station, Texas) for the mixed linear model. In the text
capture, thresholds are described to 1 decimal place
and QLV/biventricular-paced QRS described to no
decimal places, for clinical relevance.
RESULTS
Fourteen patients underwent real-time X-MRI-guided
lead implantation. Patients were age 74  5.1 years
and all were successfully implanted with a new CRT
device (13 [93%]). Twelve (86%) patients had sub-
endocardial myocardial ﬁbrosis; 2 patients had
FIGURE 3 Image Panel of Workﬂow
The ﬁrst step involves the automated segmentation and manual adjustment of the epicardial and endocardial slices to generate a 3-dimensional (3D) mesh. Endocardial
wall motion is tracked over the cardiac cycle to generate volume vs. time curves for the 16 segments. Following registration of the cine to late gadolinium enhancement
sequences, areas of myocardial ﬁbrosis are identiﬁed and both scar and dyssynchrony data are reviewed and targets selected. The 3D shell is then registered to the
x-ray (XR) once the patient is on the catheter laboratory table using ﬁducial markers, which show up white (from the CMR sequences) and gray with a central dark dot
(lead ball-bearing) from the x-ray. Vertical and horizontal translation using biplane ﬂuoroscopy is used, in addition to rotation about the x, y, and z axes to line up the
markers as demonstrated on the right hand panel. Following this process, the CMR-derived 3D model is registered to the XR system and every ﬂuoroscopic cine
demonstrates the epicardial and endocardial shell overlaid in the correct orientation.
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nonischemic cardiomyopathy (Table 1). Total proce-
dural time including CMR (45  6 min), data pro-
cessing and patient transfer/preparation (25  8 min),
and CRT implant (115  33 min) was 185  35 min.
Radiation dose area product was similar to recent
historical controls (conventional CRT implants): 1,893
 1,965 cGycm2vs. 1,582  2,122 cGycm2, p ¼ 0.72.
There were no post-operative complications and no
adverse effect on renal function despite use of intra-
venous gadolinium and iodinated contrast within a
short space of time. Of note, patients in this study had
all accessible coronary veins tested for LV lead im-
plantation compared with the historical controls, in
which this is not routine practice.
A mean of 3.6  1 epicardial coronary veins were
visible at venography (total: 51), of which 2.4  0.8
(total: 33) were judged to be viable targets for LV lead
deployment on the basis of anatomical location and
vessel caliber. Biventricular stimulation was per-
formed from these sites. A total of 56 data points
were acquired across 14 patients (range: 1 to 10)
(Online Table 1) in all possible epicardial veins.
FIGURE 4 CMR-Derived Image Overlay With Target Segment Selection
(Top left) Anteroposterior venogram with overlay of CMR-derived epicardial/endocardial shell with 16-segment American Heart Association
model showing an anterior interventricular vein. The 3D CMR-derived shell has the same colors as displayed in the guidance platform as shown
in Figures 2 and 3. Posteroseptal, anteroseptal, and anterior segments are colored in yellow, green, and blue, respectively. (Top right) left
anterior oblique (LAO) 20 venogram with automated rotation and alignment of the 16-segment model with the x-ray. Posterolateral veins are
demonstrated. (Bottom left) LAO 40 projection. Positioning of a quadripolar left ventricular lead into a preselected target segment (green).
(Bottom right) LAO 40 projection, alternate view with CMR-derived scar distribution (red). Attempted positioning and pacing using left
ventricular poles out of regions of scar.
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In some cases, multiple data points were collected
along veins using different vectors from the multi-
polar LV lead. In 10 of 14 (71%) patients, LV lead
implantation was achieved in the CMR-deﬁned target
segments based upon avoiding scar and targeting
mechanical dyssynchrony (e.g., Figure 5). The 4
remaining patients were paced in/adjacent to scar
because of a lack of coronary venous anatomy to the
target segment. Pacing in CMR-deﬁned target seg-
ments (out of scar) showed a statistically decreased
mean in the LV lead capture threshold (mean differ-
ence: 2.4 [1.5 to 3.2]; p < 0.001) and shorter biven-
tricular paced QRS duration (mean difference: 25 [15
to 34]; p < 0.001) compared with areas in areas of scar
as deﬁned by the CMR overlay. There was
no signiﬁcant difference for QLV (mean difference:
8 [-9 to 24]; p ¼ 0.35) (Table 2). Six patients had
anterior/anteroseptal scar, 5 patients had posterolat-
eral scar, 1 patient had anterolateral scar, and 2 pa-
tients had no scar. In cases where the only viable
veins were in or adjacent to scar (particularly those
with posterolateral scar), image overlay facilitated
positioning of the poles on the multipolar LV lead
away from scar as depicted in Figure 5.
DISCUSSION
This study demonstrates for the ﬁrst time the safety
and feasibility of real-time CMR-deﬁned scar and
dyssynchrony to successfully guide LV lead implan-
tation for CRT delivery in a single procedure.
Furthermore, pacing within CMR-deﬁned segments
(out of scar) showed more favorable electrical prop-
erties (lower LV capture thresholds and shorter BV-
paced QRS duration) as compared with regions of
scar, conﬁrming validity to this approach.
IMAGE-GUIDED CRT: COMPARISON WITH PREVIOUS
STUDIES. Two randomized studies have previously
shown the beneﬁt of targeted LV lead placement
over an empirical approach. The TARGET (Targeted
Left Ventricular Lead Placement to Guide Cardiac
Resynchronization Therapy) (8) and STARTER
(Speckle Tracking Assisted Resynchronization
Therapy for Electrode Region) (9) studies showed
signiﬁcant improvements in LV remodelling by using
2-dimensional speckle tracking echocardiography to
deﬁne and target late activating segments. Cardiac
imaging was however, performed at a separate sitting
prior to implantation and the images were not fused
with ﬂuoroscopy. In 11% of the patients recruited to
TARGET, guidance could not be performed due to
suboptimal imaging. The authors point out that one
of the main limitations of echocardiography is the
inability to image scar, which is of key importance
given the association between posterolateral wall scar
and poor outcomes (7). CMR in comparison has the
ability to identify and quantify both scar and dys-
synchrony and may represent the optimal imaging
modality for CRT guidance (6). A meta-analysis of 511
patients using STARTER, TARGET, and another pro-
spective cohort study (20), conﬁrmed the efﬁcacy of
an image-guided approach compared with conven-
tional implant with a higher odds ratio of response
to CRT (odds ratio: 2.1; 95% conﬁdence interval:
1.43-3.07; p < 0.0001) (21).
We have previously used CMR imaging to delineate
scar and dyssynchrony fused with ﬂuoroscopy at the
time of implantation (16,17). Using this technique,
guided placement of the LV to CMR target segments
was associated with a signiﬁcantly superior hemo-
dynamic response compared with an empirical non-
targeted approach. Furthermore, 92% of the
echocardiographic responders (>15% reduction in
end-systolic volume) were paced in a targeted CMR
target segment, compared with 50% of those who
were echo nonresponders. Because of the signiﬁcant
time previously required for the software processing
of CMR images, the scan was performed on average 2
weeks before the implant. Our current technique
represents a paradigm shift, with rapid data process-
ing, analysis, and visualization of the CMR data in the
same X-MRI laboratory in a single sitting. This
TABLE 1 Demographic Data
Age (yrs) 74  5.1
NYHA functional class 2.7  0.4
Left ventricular ejection fraction (%) 27  7.6
QRS duration (ms) 157  19
Left bundle branch block 12 (86%)
MLHFQ score (points) 27  18
6-min walking distance (m) 356  72
NT-pro BNP (ng/l) 3,429  3,136
Sinus rhythm 11 (79%)
3D Systolic dyssynchrony index (%) 15.0  7.4
Peak VO2 (ml/min/kg) 14.8  5.4
VE/VCO2 slope 38  14
Myocardial ﬁbrosis burden
(% total volume, AHA 16 segment)*
11.9  6.4
On beta blocker 79%
On ACE inhibitor 93%
On MRA 50%
On antiplatelet therapy 64%
Values are mean  SD, n (%), or %. *Scar burden calculated using prototype
platform.
ACE ¼ angiotensin-converting enzyme; BNP ¼ B-type natriuretic peptide; 3D ¼
3-dimensional; MLHFQ ¼ Minnesota Living with Heart Failure Questionnaire;
MRA ¼ magnetic resonance angiography; NYHA ¼ New York Heart Association;
peak VO2 ¼ peak oxygen uptake on cardiopulmonary exercise testing.
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FIGURE 5 Case Example With CMR-Derived Target Segments, 3D Shell Fusion With X-Ray, and Targeted LV Lead Placement
(A) Prototype guide CRT platform. Left ventricular (LV) volumes, scar burden, and dyssynchrony indices, as described in Figure 2. Myocardial scar is localized to the
posterolateral region. Target segments are selected (basal and mid-anterior, mid-anterolateral, and mid-inferior). EDV ¼ end-diastolic volume; EF ¼ ejection fraction;
ESV ¼ end-systolic volume; SD ¼ standard deviation; SV ¼ stroke volume. (B) The CMR-derived 3D shell with selected target segments in green is demonstrated
alongside the ﬁducial markers, as displayed through time-resolved angiography. (C) Left upper panel showing large anterior target segment and anterior vein. Left lower
panel showing smaller inferior target segment and vein identiﬁed. Right upper panel showing the attempted positioning of LV lead in an anterior vein; however, the lead
was unable to track distally and was unstable without any demonstrable biventricular capture. Subsequent positioning in a posterolateral vein (within the area of scar as
shown in red). Right lower panel showing lead positioning in inferior target (poles within green area). (D) QLV (sensed electrical latency) from LV lead positioned in
posterolateral vein within scar (QLV 107 ms) and biventricular paced QRS duration of 143 ms (upper panel). Electrical parameters were more favorable with LV lead with
poles within target area, out of scar (QLV 125 ms, paced QRS duration 119 ms) (lower panel). Abbreviations as in Figure 1.
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process occurs in parallel with the patient being dra-
ped and central venous access being gained. Rapid
image coregistration enables immediate image fusion
upon CS venography allowing the implanter to
perform real-time CMR-guided CRT.
Importantly, our implant times compare very
favorably with previous guided CRT studies. In
TARGET, implant time was 139  36 min in the
guidance group compared with 138  42 min in the
standard group (p ¼ NS), although screening time and
dose were higher in the guidance group (24  14 min
vs. 19  13 min, p ¼ 0.033) (9). The implant time for
our patients excluding the CMR was 115  33 min,
despite pacing in all accessible venous sites (target
and nontarget) as part of validating the system. In the
future, we envisage this system being used to directly
implant the target vein, likely being associated with
signiﬁcantly shorter implant and ﬂuoroscopy times.
CRT OUTCOMES AND MYOCARDIAL FIBROSIS. Reported
nonresponse rates to CRT are variable depending on
which outcome measure is assessed but is at least 30%
(3). Myocardial ﬁbrosis, particularly in the posterolat-
eral region where the LV lead is empirically placed, is
associated with a poor response to CRT (7). Studies
have described using CMR to avoid LV lead placement
within scar to improve CRT response (8,22) and using
multisite LV stimulation to improve hemodynamic
response in this group (23). In the current study, 36%of
patients had myocardial scar in the posterolateral
region. Given that the majority of patients undergoing
CRT have the LV lead implanted in either the lateral or
posterior walls (24), it is inevitable that the lead will be
in or adjacent to myocardial scar in a sizeable propor-
tion of cases. Prior studies have highlighted the
importance of both global scar burden (25) and regional
scar occupying the region of the LV lead (26) on CRT
outcomes. Our custom-made platform produces
information regarding percentage scar burden and
transmurality for each myocardial segment; this
knowledge may be a useful adjunct in difﬁcult cases
with a high global scar burden by guiding the
implanting physician to select those sites with the
lowest segmental scar burden and transmurality.
Furthermore, in cases in which LV lead placement in or
adjacent to scar was inevitable because of the distri-
bution of coronary venous anatomy, the CMR scar
mask was able to guide the positioning the poles (from
the multipolar LV lead) away from islands of scar to
achieve more favorable testing parameters.
LIMITATIONS AND CHALLENGES. This is a small
proof of principle study; however, a larger, random-
ized controlled study would be necessary to demon-
strate whether an image-guided approach is superior
to the standard of care, which we plan to perform.
Given that 2 previous studies using echocardiogram-
derived markers (9,10) and 2 recent studies using
multimodality imaging (27,28) have all demonstrated
improved clinical outcomes, this would infer that a
strategy of image guidance may be of clinical beneﬁt.
The use of CMR may not be feasible in all patients
because of renal impairment and claustrophobia.
Furthermore, heart failure patients especially may
struggle with being supine for extended periods;
therefore, this technique may not be suitable for all.
Scar derivation was from routine LGE sequences in a
short-axis slice format (8-mm slice, 2-mm gap), which
inevitably leads to an irregularly edged mesh with
gapping. Dyssynchrony was derived through endo-
cardial wall motion tracking on routine cine imaging
and volume vs. time curves used to identify segments
with latest mechanical activation rather than a pure
strain calculation. It could be argued that one cannot
exclude passive wall motion when tracking the
endocardial surface only; however, similar tracking
algorithms (using cine CMR) have shown good
agreement with strain derived from myocardial
tagging (the gold standard for measuring strain) (29).
We anticipate future iterations of the platform to
include scar analysis from LGE sequences with higher
spatial resolution (higher number of slices or 3D scar)
and calculation of dyssynchrony through a range of
different metrics including cine sequence–derived
strain, as described previously (27). In this study, of
importance was that the spatial and temporal
resolution were the same as for routine scanning;
however, more elaborate and reﬁned sequences may
be able to be incorporated in the near future. Last, we
intentionally studied a predominantly ischemic
population, given that they have the most to gain
TABLE 2 Comparison of Electrical Properties Based on Whether
the LV Lead Was In or Out of Areas of Scar, Determined by the
CMR Overlay
Mean
Difference 95% CI p Value
LV lead capture
threshold (volts)
2.35 1.54 to 3.15 <0.001
QLV (ms) 7.78 -8.63 to 24.20 0.35
BV-paced QRS
duration (ms)
24.61 15.24 to 33.97 <0.001
Mixed-effect model for all data points comparing those in and out of scar, as
determined by the CMR overlay visualization using the purpose-built platform
(raw data output, to 2 decimal places). A total of 56 data points were compared
across 14 patients.
BV ¼ biventricular; CI ¼ conﬁdence interval; QLV ¼ ﬁrst ventricular depolari-
zation (earliest onset QRS duration on surface 12-lead electrocardiogram) to the
nadir signal on the LV lead electrogram; LV ¼ left ventricular.
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from a technique that may be able to improve CRT
response. Response rates in nonischemic patients are
indeed signiﬁcantly higher; we would therefore
advocate studying a larger number of these patients
to evaluate the platform from the perspective of im-
age guidance using dyssynchrony parameters alone.
Coronary venous anatomy has been described
using 3D whole heart sequences (electrocardiogram-
triggered, respiratory-navigated, steady-state free-
precession inversion recovery) applied to the whole
heart over a short period (e.g., 60 to 80 ms), obtaining
spatial resolution of 1.5  1.5  2 mm (30). However,
this process adds at least 30 min of scanning time
and, furthermore, the coronary veins require seg-
mentation to extract onto the 3D mesh model, which
can be time consuming and limit the applicability of
data utilization in real time. Furthermore, heart fail-
ure patients may have worsened breathing when
lying supine; therefore, we wanted to keep scanning
time to a minimum, before the implant, which also
requires them to lie ﬂat.
An increasing proportion of patients undergoing
CRT are upgrades from existing devices and, despite
the increasing availability of magnetic resonance
conditional pacing systems (31), signiﬁcant artifact
image degradation would limit the use of a CMR-based
guidance platform. We have previously shown
computed tomography (CT) imaging merged with
ﬂuoroscopy can facilitate LV lead implantation in
previously failedLV lead implantswith visualization of
CS anatomy (32). Furthermore, cardiac CTmay provide
a feasible alternative to CMR; measures of strain have
shown to correlate between the 2 imagingmodalities in
an animal model (33) and scar can be demonstrated
(34). We envisage using a similar guidance platform
with CT data in a similar way in the future.
Given the expense of CMR in some centers, this
technique may not be cost-effective; however, the
data could be processed offsite and fed back to the
core site. The current technique of single-sitting CMR
and implant requires an X-MRI laboratory, which is
not available in all centers. It is envisaged, however,
that in the future, with improved image registration
techniques not requiring ﬁducial markers, the CMR
platform could be used in an ofﬂine manner
with scanning and implantation in separate locations
and times.
Finally, it is notable that only 71% of patients were
able to have the LV lead delivered to the target
segment; this is similar to our previous study of CMR
guidance (15). This usually occurs from the lack of a
coronary vein subtending the target segments. This
may be viewed not as a limitation but as an advantage
of the system. One may argue that in those cases in
which the target segments are not subtended by
viable epicardial veins, the conventional epicardial
approach may be switched to an endocardial LV
approach at the outset. Endocardial pacing has been
shown to be of use in nonresponders to conventional
CRT (35); however, the optimal site of stimulation
varies greatly between patients (4,36,37). The value
of such a system may be to both identify patients in
whom such an approach is required and to then use
the system to perform targeted endocardial LV lead
implantation. Recently, we have shown that such a
targeted approach for endocardial LV stimulation
using CMR guidance to avoid scar results in improved
hemodynamic response (38).
CLINICAL RELEVANCE AND FUTURE DIRECTIONS. Image
guidance is likely to lead to improved response rates
in patients undergoing CRT implantation. The ability
of CMR to image scar as well as dyssynchrony would
appear to make it the ideal clinical tool for such
guidance and may result in improved responder
rates. The ability to perform imaging and guidance in
1 sitting may be attractive for both the patient and
clinician and may result in a more cost-effective
approach to CRT. The development of LV endocar-
dial pacing and the use of leadless pacemaker systems
that can be deployed into the LV endocardium (39)
are likely to be used increasingly in the future,
especially in patients who are likely to respond poorly
to standard CRT. Endocardial LV pacing is highly site
speciﬁc, and the use of such an imaging platform to
guide endocardial LV stimulation sites may be
extremely important in the future.
CONCLUSIONS
Real-time CMR guidance for optimal LV lead place-
ment in delivering CRT is safe and feasible and can be
performed in a single procedure. Larger scale studies
are needed to ascertain whether this process will lead
to improved clinical outcome.
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